Literature DB >> 32374771

Hematological malignancies in East Africa-Which cancers to expect and how to provide services.

Steven Alan Leak1, Lilian Gasper Mmbaga1, Elifuraha Wilson Mkwizu1, Priscus John Mapendo1, Oliver Henke1.   

Abstract

BACKGROUND: Sub-Saharan Africa (SSA) has an increasing non-communicable disease burden. Tanzania has an incidence of more than 35,000 cancer cases per year with an 80% mortality rate. Hematological malignancies account for 10% of these cases. The numbers will double within the next 10 years due to demographic changes, better diagnostic capabilities and life style changes. Kilimanjaro Christian Medical Centre established a Cancer Care Centre (CCC) in December 2016 for a catchment area of 15 million people in Northern Tanzania. This article aims to display the hematological diagnosis and characteristics of the patients as well as to describe the advancements of hematologic services in a low resource setting.
METHODS: A cross-sectional analysis of all hematological malignancies at CCC from December 2016 to May 2019 was performed and a narrative report provides information about diagnostic means, treatment and the use of synergies.
RESULTS: A total of 209 cases have been documented, the most common malignancies were NHL and MM with 44% and 20%. 36% of NHL cases, 16% of MM cases and 63% of CML cases were seen in patients under the age of 45. When subcategorized, CLL/SLL cases had a median age was 56.5, 51 years for those with other entities of NHL. Sexes were almost equally balanced in all NHL groups while clear male predominance was found in HL and CML. DISCUSSION: Malignancies occur at a younger age and higher stages than in Western countries. It can be assumed that infections play a key role herein. Closing the gap of hematologic services in SSA can be achieved by adapting and reshaping existing infrastructure and partnering with international organizations.

Entities:  

Year:  2020        PMID: 32374771     DOI: 10.1371/journal.pone.0232848

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  3 in total

1.  A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990-2017.

Authors:  Mohammad Keykhaei; Masood Masinaei; Esmaeil Mohammadi; Sina Azadnajafabad; Negar Rezaei; Sahar Saeedi Moghaddam; Nazila Rezaei; Maryam Nasserinejad; Mohsen Abbasi-Kangevari; Mohammad-Reza Malekpour; Seyyed-Hadi Ghamari; Rosa Haghshenas; Kamyar Koliji; Farzad Kompani; Farshad Farzadfar
Journal:  Exp Hematol Oncol       Date:  2021-02-08

2.  Hematological malignancies in the Northwest Ethiopia.

Authors:  Bamlaku Enawgaw; Melak Aynalem; Mulugeta Melku; Fikir Asrie; Molla Abebe; Aregawi Yalew; Tiruzer Bekele; Nebiyu Mesfin; Mulugeta Ayalew; Elias Shiferaw
Journal:  PLoS One       Date:  2021-12-01       Impact factor: 3.240

3.  Use of Herbal Medicine Is Associated With Late-Stage Presentation in Tanzanian Patients With Cancer: A Survey to Assess the Utilization of and Reasons for the Use of Herbal Medicine.

Authors:  Oliver Henke; Walter Bruchhausen; Anna Massawe
Journal:  JCO Glob Oncol       Date:  2022-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.